Advanced Search

Technical Analysis for AXDX - Accelerate Diagnostics, Inc.

Grade Last Price % Change Price Change
grade B 15.5 5.44% 0.80
AXDX closed up 5.44 percent on Friday, August 7, 2020, on 82 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical AXDX trend table...
Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
New Uptrend Bullish 0.00%
Wide Range Bar Range Expansion 0.00%
Earnings Movers Other 0.00%
New Downtrend Bearish 5.44%
Golden Cross Bullish 5.44%
Earnings Movers Other 5.44%
Narrow Range Bar Range Contraction -0.64%
NR7 Range Contraction -0.64%
NR7-2 Range Contraction -0.64%
Older EOD signals for AXDX ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Accelerate Diagnostics, Inc. engages in the research and development and commercialization of proprietary surface chemistry formulation and quantitative bio-analytical measurement instruments. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corp. and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.
Technology Agilent Technologies Bacterial Infections

Is AXDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 8 Accelerate Diagnostics (AXDX) CEO Jack Phillips on Q2 2020 Results - Earnings Call Transcript
Aug 7 80 Stocks Moving In Friday's Mid-Day Session
Aug 6 Accelerate Diagnostics EPS misses by $0.01, misses on revenue
Aug 6 The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
Aug 2 The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Jul 30 Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Jul 17 Need To Know: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Insiders Have Been Buying Shares
Jul 16 Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
Jun 25 Accelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping Up
Jun 15 Faruqi & Faruqi, LLP is Investigating Accelerate Diagnostics, Inc. (AXDX) on Behalf of its Shareholders
See more AXDX news...

Indicators

Indicator Value
52 Week High 22.13
52 Week Low 4.53
Average Volume 499,465
200-Day Moving Average 13.51
50-Day Moving Average 13.67
20-Day Moving Average 15.98
10-Day Moving Average 14.95
Average True Range 1.28
ADX 26.43
+DI 28.39
-DI 16.64
Chandelier Exit (Long, 3 ATRs ) 15.28
Chandelier Exit (Short, 3 ATRs ) 17.50
Upper Bollinger Band 18.32
Lower Bollinger Band 13.63
Percent B (%b) 0.4
BandWidth 29.34
MACD Line 0.18
MACD Signal Line 0.44
MACD Histogram -0.2547
Fundamentals Value
Market Cap 853.51 Million
Num Shares 55.1 Million
EPS -1.23
Price-to-Earnings (P/E) Ratio -12.60
Price-to-Sales 778.36
Price-to-Book 7.08
PEG Ratio -0.51
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.37
Resistance 3 (R3) 19.71 18.77 18.73
Resistance 2 (R2) 18.77 17.78 18.60 18.51
Resistance 1 (R1) 17.13 17.17 16.66 16.79 18.29
Pivot Point 16.19 16.19 15.95 16.02 16.19
Support 1 (S1) 14.55 15.20 14.08 14.21 12.71
Support 2 (S2) 13.61 14.59 13.44 12.49
Support 3 (S3) 11.97 13.61 12.28
Support 4 (S4) 11.63